# Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at Altitude

> **NCT05036980** · PHASE1 · COMPLETED · sponsor: **Diffusion Pharmaceuticals Inc** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers With Induced Hypoxia

## Interventions

- **DRUG:** Trans Sodium Crocetinate

## Key facts

- **NCT ID:** NCT05036980
- **Lead sponsor:** Diffusion Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-09
- **Primary completion:** 2022-04-08
- **Final completion:** 2022-04-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05036980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05036980, "Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at Altitude". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05036980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*